LINES

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This is a multi-centre international Phase 2 trial of Linsitinib in advanced Ewing Sarcoma

Primary Objectives

To determine the pharmacodynamic effect of linsitinib in the tumour
To evaluate the safety and tolerability of linsitinib

Trial Publications

The narrative publication can be found here.